Equity - Additional Information (Detail)						1 Months Ended	3 Months Ended	12 Months Ended
	Jun. 06, 2022 $ / shares shares	Nov. 03, 2021 USD ($) shares	Oct. 18, 2021 $ / shares shares	Oct. 14, 2021	Oct. 07, 2021	Mar. 31, 2021 shares	Mar. 31, 2021 shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Class of Stock [Line Items]
Common stock, shares authorized (in shares)								2,923,900,005	2,923,900,005
Common stock, par value (in dollars per share) | $ / shares								$ 0.000017100448	$ 0.000017100448
Convertible preferred stock, shares issued upon conversion (in shares)		64,467,176
Stockholders' equity note, stock split, conversion ratio				5.8478	5.8478
Dividends preferred stock | $								$ 0	$ 0
Percentage of original purchase price plus accrued but unpaid dividends								100
Warrants issued during period (in shares)						3
Class of warrants or rights number of securities covered by the warrants or rights (in shares)						125,000	125,000
Percentage of diluted equity of warrants							12.50%
Earnings attributable to noncontrolling interest | $								$ 0	$ 0
Tarsus Warrants
Class of Stock [Line Items]
Number of securities called by each warrant or right (in shares)			156,746
Tarsus Pharmaceuticals | Warrants To Purchase Common Stock
Class of Stock [Line Items]
Warrants issued during period (in shares)			2			3
Class of warrants or rights number of securities covered by the warrants or rights (in shares)						125,000	125,000
Issuance of ordinary shares upon initial public offering, net of issuance costs (in shares)	78,373	78,373
Class of warrants or rights exercise price (in dollars per share) | $ / shares	$ 0.000017100448		$ 0.000017100448
Warrants exercised during period (in shares)			1
Series Seed Redeemable Convertible Preferred Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)		32,162,900
Mezzanine equity | $		$ 55,000,000
Series A Redeemable Convertible Preferred Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)		32,304,276
Mezzanine equity | $		$ 297,700,000
Maximum
Class of Stock [Line Items]
Common stock, shares authorized (in shares)								2,923,900,005